Literature DB >> 18579609

CD4 binding affinity determines human immunodeficiency virus type 1-induced alpha interferon production in plasmacytoid dendritic cells.

Sabrina Haupt1, Norbert Donhauser, Chawaree Chaipan, Philipp Schuster, Bridget Puffer, Rod S Daniels, Thomas C Greenough, Frank Kirchhoff, Barbara Schmidt.   

Abstract

Plasmacytoid dendritic cells (PDC) are major producers of type I interferons (IFN) in response to human immunodeficiency virus type 1 (HIV-1) infection. To better define the underlying mechanisms, we studied the magnitude of alpha IFN (IFN-alpha) induction by recombinant viruses containing changes in the Env protein that impair or disrupt CD4 binding or expressing primary env alleles with differential coreceptor tropism. We found that the CD4 binding affinity but not the viral coreceptor usage is critical for the attachment of autofluorescing HIV-1 to PDC and for subsequent IFN-alpha induction. Our results illustrate the importance of the gp120-CD4 interaction in determining HIV-1-induced immune stimulation via IFN-alpha production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579609      PMCID: PMC2519661          DOI: 10.1128/JVI.00196-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus.

Authors:  S Patterson; A Rae; N Hockey; J Gilmour; F Gotch
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors.

Authors:  S Feldman; D Stein; S Amrute; T Denny; Z Garcia; P Kloser; Y Sun; N Megjugorac; P Fitzgerald-Bocarsly
Journal:  Clin Immunol       Date:  2001-11       Impact factor: 3.969

3.  Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection.

Authors:  J Pacanowski; S Kahi; M Baillet; P Lebon; C Deveau; C Goujard; L Meyer; E Oksenhendler; M Sinet; A Hosmalin
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

4.  Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks.

Authors:  W Resch; N Hoffman; R Swanstrom
Journal:  Virology       Date:  2001-09-15       Impact factor: 3.616

5.  Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection.

Authors:  F P Siegal; P Fitzgerald-Bocarsly; B K Holland; M Shodell
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

6.  Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.

Authors:  H Donaghy; A Pozniak; B Gazzard; N Qazi; J Gilmour; F Gotch; S Patterson
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

7.  Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy.

Authors:  Jennifer S Finke; Michael Shodell; Kokila Shah; Frederick P Siegal; Ralph M Steinman
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

8.  Natural interferon alpha/beta-producing cells link innate and adaptive immunity.

Authors:  N Kadowaki; S Antonenko; J Y Lau; Y J Liu
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

9.  Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties.

Authors:  M Detheux; L Ständker; J Vakili; J Münch; U Forssmann; K Adermann; S Pöhlmann; G Vassart; F Kirchhoff; M Parmentier; W G Forssmann
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

10.  BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction.

Authors:  A Dzionek; Y Sohma; J Nagafune; M Cella; M Colonna; F Facchetti; G Günther; I Johnston; A Lanzavecchia; T Nagasaka; T Okada; W Vermi; G Winkels; T Yamamoto; M Zysk; Y Yamaguchi; J Schmitz
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  13 in total

1.  Plasmacytoid dendritic cells reduce HIV production in elite controllers.

Authors:  K Machmach; M Leal; C Gras; P Viciana; M Genebat; E Franco; F Boufassa; O Lambotte; J P Herbeuval; E Ruiz-Mateos
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms.

Authors:  Natalia J Reszka-Blanco; Vijay Sivaraman; Liguo Zhang; Lishan Su
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

Review 3.  Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.

Authors:  Patricia Fitzgerald-Bocarsly; Evan S Jacobs
Journal:  J Leukoc Biol       Date:  2010-02-09       Impact factor: 4.962

Review 4.  Plasmacytoid dendritic cells in HIV infection.

Authors:  Meagan O'Brien; Olivier Manches; Nina Bhardwaj
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 5.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

Review 6.  Dendritic cell dysregulation during HIV-1 infection.

Authors:  Elizabeth Miller; Nina Bhardwaj
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

7.  Co-ordinated regulation of plasmacytoid dendritic cell surface receptors upon stimulation with herpes simplex virus type 1.

Authors:  Philipp Schuster; Norbert Donhauser; Kathrin Pritschet; Moritz Ries; Sabrina Haupt; Nicolai A Kittan; Klaus Korn; Barbara Schmidt
Journal:  Immunology       Date:  2009-09-09       Impact factor: 7.397

8.  Innate sensing of HIV-infected cells.

Authors:  Alice Lepelley; Stéphanie Louis; Marion Sourisseau; Helen K W Law; Julien Pothlichet; Clémentine Schilte; Laurence Chaperot; Joël Plumas; Richard E Randall; Mustapha Si-Tahar; Fabrizio Mammano; Matthew L Albert; Olivier Schwartz
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

9.  Effect of type-I interferon on retroviruses.

Authors:  Esperanza Gómez-Lucía; Victorio M Collado; Guadalupe Miró; Ana Doménech
Journal:  Viruses       Date:  2009-10-27       Impact factor: 5.048

Review 10.  Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation.

Authors:  Moritz Ries; Kathrin Pritschet; Barbara Schmidt
Journal:  Clin Dev Immunol       Date:  2011-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.